.jpg)
Advanz Pharma has emerged as a global frontrunner in the pharmaceutical industry, with a specific focus on specialty, hospital, and rare disease medicines. Their core mission is to enhance patient’s lives by providing innovative and effective medical solutions.
Company Overview
Headquartered in London, UK, Advanz Pharma has a significant global footprint with sales in over 90 countries worldwide. They have direct commercial operations in more than 20 countries, including key markets such as Europe, the US, Canada, and Australia.
Global Presence and Distribution Network
Their global presence is further bolstered by an established Centre of Excellence in Mumbai, India, and a robust distribution and commercialization partner network.
Diverse Product Portfolio
Advanz Pharma boasts a comprehensive product portfolio and pipeline, including innovative medicines, specialty generics & biosimilars, and originator brands. These products cover an extensive range of therapeutic areas:
Hepatology
Gastroenterology
Anti-infectives
Critical Care
Endocrinology
Oncology
CNS
Rare Disease Medicines
Strategic Partnerships
Advanz Pharma has set a high ambition to become the partner of choice for the commercialization of specialty, hospital, and rare disease medicines in Europe, Canada, and Australia. This ambition aligns perfectly with their strategy to collaborate with biopharma and development companies to bring medicines to patients.
Team and Values
Their success is largely attributed to their dedicated and highly qualified team of employees who uphold the company values of entrepreneurship, speed, and integrity.
print("Advanz Pharma is leading the way in providing innovative and specialty medical solutions to patients globally.")
"Our ambition is to be a partner of choice for the commercialization of specialty, hospital, and rare disease medicines in Europe, Canada, and Australia." - Advanz Pharma
Conclusion
With their commitment to improving patient lives, strategic partnerships, and a diverse product portfolio, Advanz Pharma is indeed revolutionizing the global pharmaceutical industry.
Global Presence: Commercial sales in more than 90 countries worldwide.
Diverse Product Portfolio: Innovative medicines, specialty generics & biosimilars, and originator brands.
Strategic Partnerships: Collaborations with biopharma and development companies.
By upholding their company values of entrepreneurship, speed, and integrity, they continue to be at the forefront of providing specialty, hospital, and rare disease medicines.
Comentários